| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Galera Therapeutics, Inc. | Chief Legal & Compliance Officer | Stock Option (Right to Buy) | 135K | Feb 25, 2023 | Direct | ||
| Context Therapeutics Inc. | Director | Stock Option (right to buy) | 25K | Jun 13, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CNTX | Context Therapeutics Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
| CNTX | Context Therapeutics Inc. | May 31, 2023 | 1 | $0 | 4 | May 31, 2023 | Director |
| GRTX | Galera Therapeutics, Inc. | Feb 25, 2023 | 1 | $0 | 4 | Feb 28, 2023 | Chief Legal & Compliance Officer |
| CNTX | Context Therapeutics Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 3, 2022 | Director |
| GRTX | Galera Therapeutics, Inc. | Feb 28, 2022 | 1 | $0 | 4 | Mar 2, 2022 | Chief Legal & Compliance Officer |
| CNTX | Context Therapeutics Inc. | Oct 19, 2021 | 0 | $0 | 3 | Oct 19, 2021 | Director |
| GRTX | Galera Therapeutics, Inc. | Oct 8, 2021 | 1 | $0 | 4 | Oct 12, 2021 | Chief Legal and Compliance Officer |
| GRTX | Galera Therapeutics, Inc. | Oct 8, 2021 | 0 | $0 | 3 | Oct 12, 2021 | Chief Legal and Compliance Officer Exhibit List: Exhibit 24 - Power of Attorney |